A Difficult Case of Optic Neuropathy: Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD)

Celine Noha Haeller,Thierry Badoux,Friedrich Medlin,Lionel Arlettaz,Philippe DeGottrau,Eva Grams,Manolito Lucas Finger,Vincent Dunet,Marie-Claire Gaillard

DOI: https://doi.org/10.1055/a-2218-8352

2024-04-25

Klinische Monatsblätter für Augenheilkunde

Abstract:Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is a recently defined inflammatory demyelinating disease, that generally affects the optic nerve (ON) in adults and the central nervous system in children [1], [2]. The specific clinical phenotype, radiological findings, and neurological manifestations enable its distinction from other central nervous system inflammatory demyelinating diseases (CNS IDDs) such as aquaporine-4-IgGQ neuromyelitis optica spectrum disorder (NMOSD) and multiple sclerosis (MS) [3] [4] [5]. Received: 27 October 2023 Accepted: 27 November 2023 Article published online: 23 April 2024 © 2024. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany

ophthalmology